Xopenex (Akorn, Inc.)
Welcome to the PulseAid listing for the Xopenex drug offered from Akorn, Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Levalbuterol Hydrochloride |
SUBSTANCE NAME: | LEVALBUTEROL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-02-27 |
END MARKETING DATE: | 0000-00-00 |
Xopenex HUMAN PRESCRIPTION DRUG Details:
Item Description | Xopenex from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.31(mg/3mL) |
START MARKETING DATE: | 2015-02-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-172_fb96eca6-a94c-4baa-8156-9a1395ead5db |
PRODUCT NDC: | 17478-172 |
APPLICATION NUMBER: | NDA020837 |
Other LEVALBUTEROL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: